Bladder Cancer - Results from #120

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience. July 23, 2021

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study. July 22, 2021

Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer. July 22, 2021

PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue? July 21, 2021

Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors. July 21, 2021

Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy. July 21, 2021

Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow up. July 20, 2021

Immune Checkpoint Inhibitors in the Management of Urothelial Carcinoma. July 20, 2021

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer. July 19, 2021

Approaches to Non-Muscle-Invasive Bladder Cancer. July 19, 2021

Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis. July 19, 2021

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort. July 16, 2021

Dissecting the role of radical cystectomy and urinary diversion in post-operative complications: an analysis using the American College of Surgeons national surgical quality improvement program database. July 16, 2021

A Contemporary Clinicopathologic Analysis of Primary Urothelial Carcinoma of the Urethra Without Concurrent Renal Pelvic, Ureteral, or Bladder Carcinoma. July 16, 2021

Sesen Bio Announces Productive Late-Cycle Meeting with the FDA for Vicineum™ July 15, 2021

Clinical outcomes of reresection in patients with high-risk nonmuscle-invasive bladder cancer treated with en bloc transurethral resection: a retrospective study with a 1-year follow-up. July 15, 2021

Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC? July 14, 2021

Bladder Cancer Advocacy Network Announces $600,000 in Awards to Propel Bladder Cancer Research Innovation July 13, 2021

The impact of the social construct of race on outcomes among bacille Calmette-Guérin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting. July 13, 2021

Association of current molecular subtypes in urothelial carcinoma with patterns of muscularis propria invasion. July 13, 2021

Page 7 of 406